National Lab Briefs

Volume: 3, #3The Scientist February 6, 1989 NATIONAL LAB BRIEFS Plasma Lab Chilled By DOE If the last three months are any indication, it's going to be a tough year for the Princeton Plasma Physics Laboratory. In November Robert Hunter, director of DOE's Office of Energy Research, dropped a bombshell by withdrawing $12.5 million of the $20 million that the lab had already committed to remodeling the Tokamak Fusion Test Reactor to make possible higher energies. Hunter is said

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

If the last three months are any indication, it's going to be a tough year for the Princeton Plasma Physics Laboratory. In November Robert Hunter, director of DOE's Office of Energy Research, dropped a bombshell by withdrawing $12.5 million of the $20 million that the lab had already committed to remodeling the Tokamak Fusion Test Reactor to make possible higher energies. Hunter is said to prefer programs more likely to show quick results. A howl of protest from the lab led Hunter to return $6.5 million of the funds, however, leaving what lab director Harold Furth wryly calls a deficit "shrewdly calculated to be oppressive, but not impossible." But the new year brought more bad news. Last February DOE promised to provide $31 million for the construction of a complementary facility, the Compact Ignition Tokamak. Yet in its proposed 1990 budget, released last month, DOE requested only $5.5 million for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies